US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Health Innovation Active ETF

34.41

-0.1816-0.53%

Volume:1K

Turnover:46.45K

Market Cap:13.76M

PE:- -

High:34.41

Open:34.24

Low:34.24

Close:34.59

52wk High:34.79

52wk Low:25.79

Shares:400.00K

Float Shares:400.00K

Volume Ratio:0.36

T/O Rate:0.34%

Dividend:0.08

Dividend Rate:0.24%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (GEHC), Biogen (BIIB) and BeOne Medicines (ONC)

Merck price target raised to $180 from $155 at Wolfe Research

Merck (MRK) Stock May Be 35% Undervalued After Cancer Vaccine Data

Simply Wall St.

US FDA Expands Approval for J&J's Drug for Rare Blood Disorder

FDA Approves J&J Imaavy for Warm Autoimmune Hemolytic Anemia Treatment

FDA Approves Imaavy® as First-Ever Treatment for Warm Autoimmune Hemolytic Anemia (Waiha), Representing a Landmark Advancement for Patients

THOMSON REUTERS

Moderna Inc. Stock Slides 4.3%, Underperforms Peers

Lakefront Biotherapeutics Wins FDA Orphan Drug Status for Gamgertamig in Pemphigus

Syngenis banks R&D refund to fuel biotech build-out

The West Australian

Moderna is Betting Big on Its Cancer Vaccine. This is What Wall Street Wants to See.

Renalytix Discloses Director’s Link to Trellus Administration as KidneyIntelX Rollout Advances

Biogen, Eisai's LEQEMBI IQLIK Now Available in US for Early Alzheimer's Disease

MT Newswires Live

Eisai, Biogen announces once weekly lecanemab-irmb availability in the U.S.

Eisai Co., Ltd.: Leqembi Iqlik (Lecanemab-Irmb) Autoinjector for Initiation of Therapy NOW Available in U.S. for Early Alzheimer's Disease

THOMSON REUTERS

CF PHARMTECH (02652) Secures Expanded Clinical Trial Approval for ICF001 Across Additional Indications

Barclays Raises Moderna PT on 'transformative' Melanoma Vaccine Potential

EU Commission Approves Gilead Trodelvy-Keytruda Combo for First-Line PD-L1+ Metastatic TNBC

Gilead - EU Grants Marketing Authorization for Trodelvy with Keytruda in First-Line Pd-L1-Positive Metastatic Tnbc

THOMSON REUTERS

European Commission Expands Role of Gilead’s Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer Across Pd-L1 Status

THOMSON REUTERS

BAO PHARMA-B (02659) Receives US FDA Clearance for KJ015 Injection Clinical Trial Application

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/BMED/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BMED","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","market":"US","secType":"STK","nameCN":"iShares Health Innovation Active ETF","latestPrice":34.4051,"timestamp":1787601600000,"preClose":34.5867,"halted":0,"volume":1353,"delay":0,"changeRate":-0.0052505731972117345,"floatShares":400000,"shares":400000,"eps":0,"marketStatus":"Pre-Mkt","change":-0.1816,"latestTime":"08-25 06:47:15 EDT","open":34.24,"high":34.4051,"low":34.24,"amount":46450,"amplitude":0.004774,"askPrice":54.7,"askSize":100,"bidPrice":13.84,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787664600000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":34.4051,"sharesOutstanding":360000,"nav":34.566084000000004,"aum":13826433.6,"dividendRate":0.002401,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":34.27,"preClose":34.4051,"latestTime":"16:10 EDT","volume":6,"amount":206.4306,"timestamp":1787602204415,"change":-0.1351,"changeRate":-0.003927,"amplitude":0},"volumeRatio":0.3553046059869267,"impliedVol":0.3098,"impliedVolPercentile":0.792},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","floatShares":400000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.3553046059869267,"shares":400000,"dividePrice":0.0826,"high":34.4051,"amplitude":0.004774,"preClose":34.5867,"low":34.24,"week52Low":25.794,"pbRate":"--","week52High":34.7939,"institutionHeld":0,"latestPrice":34.4051,"eps":0,"divideRate":0.002401,"volume":1353,"delay":0,"ttmEps":0,"open":34.24,"prevYearClose":30.32,"prevWeekClose":34.5867,"prevMonthClose":30.9904,"prevQuarterClose":30.62,"fiveDayClose":32.4416,"twentyDayClose":30.7632,"sixtyDayClose":28.5717},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMED\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"BMED","amount":0.08118,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Health Innovation Active ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2023-12-20","symbol":"BMED","amount":0.007207,"announcedDate":"2023-12-20","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"BlackRock Future Health ETF","recordDate":"2023-12-27","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMED\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-27","value":0.007207,"currency":"USD"},{"executeDate":"2026-06-15","recordDate":"2026-06-15","paymentDate":"2026-06-18","value":0.08118,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMED\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BMED\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662273574","title":"Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (GEHC), Biogen (BIIB) and BeOne Medicines (ONC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662273574","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662273574?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:40","pubTimestamp":1787654408,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on GE Healthcare Technologies Inc (GEHC), Biogen (BIIB)...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ge-healthcare-technologies-inc-gehc-biogen-biib-and-beone-medicines-onc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ge-healthcare-technologies-inc-gehc-biogen-biib-and-beone-medicines-onc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0354030511.USD","PPA","LU1551013425.SGD","XLV","LU2756315664.SGD","ONC","DFEN","BK4139","MISL","MDCO","LU2543165471.USD","XAR","LGHT","GEHC","LU2264538146.SGD","XBI","LU1551013342.USD","BK4588","LU0354030438.USD","LU0109394709.USD","LU0889565916.HKD","PBE","ITA","BK4526","LU1988902786.USD","BK4581","LABU","LU2168564065.EUR","GE","BK4187","LU0077335932.USD","BK4543","BMED","NATO","IE00B894F039.SGD","LU0689472784.USD","LU1280957306.USD","LU0868494617.USD","BK4082","TRUI","BIIB","IE00B19Z9P08.USD","LU1366192091.USD","UXI","EXI","LU2168564222.USD","LU1066051498.USD","LU0689626769.HKD","LU0353189763.USD","LU0943347566.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662733962","title":"Merck price target raised to $180 from $155 at Wolfe Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2662733962","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662733962?lang=en_us&edition=fundamental","pubTime":"2026-08-25 17:55","pubTimestamp":1787651717,"startTime":"0","endTime":"0","summary":"Wolfe Research analyst Alexandria Hammond raised the firm’s price target on Merck (MRK) to $180 from $155 and keeps an Outperform rating on the sha...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/merck-price-target-raised-to-180-from-155-at-wolfe-research-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/merck-price-target-raised-to-180-from-155-at-wolfe-research-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0965508806.USD","LU1934455194.USD","LU0980610538.SGD","LU2357627491.SGD","LU0211331839.USD","IE00BBT3K403.USD","LU1037948897.HKD","LU1201861249.SGD","MRK","BK4007","IE00BSNM7G36.USD","LU2125154935.USD","LU1929549753.HKD","LU1162221912.USD","IE00BJJMRZ35.SGD","LU0985320562.USD","PAWZ","SG9999002232.USD","LU0965509010.AUD","BMED","IXJ","IE00BFTCPJ56.SGD","LU0122379950.USD","VHT","LU0868494708.USD","GDOC","SGXZ57979304.SGD","LU0289739699.SGD","XLV","LU0265550946.USD","LU2491050071.SGD","LU1066053197.SGD","LU1430594728.SGD","LU1066051811.HKD","LU2125909247.SGD","LU1934455277.USD","LU0320765489.SGD","LU0203345920.USD","LU0965509101.SGD","LU1066051225.USD","LU2106854487.HKD","PPH","LU0320765646.SGD","LU0265550359.USD","JDOC","LU2491049909.HKD","IE00B4R5TH58.HKD","SG9999014575.USD","BK4534","LU1035773651.USD","LU0266013472.USD","LU0477156953.USD","LU1941712264.USD","LU0432979614.USD","LU0689626769.HKD","LU2125909593.SGD","LU0823416689.USD","IE00B2B36J28.USD","LU1989772840.SGD","IE00B1BXHZ80.USD","LU1069347547.HKD","IYH","LU1917777945.USD","LU2461242641.AUD","LU0942090050.USD","LU0203347892.USD","HRTS","IE00BLSP4452.SGD","LU2468319806.SGD","SG9999014542.SGD","LU1571399168.USD","LU1116320737.USD","LU0058720904.USD","LU2361044949.HKD","LU1989771016.USD","LU0859254822.USD","LU0648001328.SGD","LU0098860793.USD","LU1116320901.HKD","BK4559","SG9999015358.SGD","IE0002141913.USD","LU1974910355.USD","LU0130517989.USD","IE0009355771.USD","LU2361045086.USD","LU2360032135.SGD","LU0234572021.USD","LU1057294990.SGD","LU1989772923.USD","IE00BN8TJ469.HKD","LU0208291251.USD","LU0868494617.USD","BK4516","RXL","SG9999014567.USD","LU0006306889.USD","LU2125154778.USD","LU1037948541.HKD","LU1061106388.HKD","FHLC","LU0861579265.USD","LU1585245621.USD","SG9999001176.USD","SG9999015341.SGD","BK4550","LU0124676726.USD","LU1291159041.SGD","LU1023059063.AUD","LU2089984988.USD","IE000M9KFDE8.USD","SG9999013999.USD","FTXH","BK4585","TRUH","LU1066051498.USD","LU1923622614.USD","LU0130102774.USD","LU2491050154.USD","LU2112291526.USD","SG9999001176.SGD","IE00BJT1NW94.SGD","LU1983299246.USD","LU1941712348.USD","LU1934455863.HKD","BK4533","BK4588","LU2023250504.SGD","IHE","LU0070302665.USD","LU0965509283.SGD","LU2023250843.SGD","LU2433249047.HKD","LU0106261372.USD","IE00BLSP4239.USD","LU1699723380.USD","SG9999001440.SGD","LU1093756325.SGD","LU2324357040.USD","SG9999002224.SGD","LU2361044865.SGD","LU1093756168.USD","LU0238689110.USD","SG9999014559.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662620741","title":"Merck (MRK) Stock May Be 35% Undervalued After Cancer Vaccine Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2662620741","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662620741?lang=en_us&edition=fundamental","pubTime":"2026-08-25 07:24","pubTimestamp":1787613868,"startTime":"0","endTime":"0","summary":"Merck stock has delivered a strong 130.2% return over the past 5 years, yet its valuation picture is split, with a Discounted Cash Flow (DCF) estimate pointing to meaningful upside while market multiples lean the other way.\n\nOver 5 years, Merck has returned 130.2%, which puts recent enthusiasm for the story firmly in focus for anyone thinking about new money going into the stock.\nRecent progress in oncology, including the personalized mRNA melanoma vaccine with Moderna and broader use of...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/288502-main-header/1756255043815","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/288502-main-header/1756255043815"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-mrk/merck/news/merck-mrk-stock-may-be-35-undervalued-after-cancer-vaccine-d","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-mrk/merck/news/merck-mrk-stock-may-be-35-undervalued-after-cancer-vaccine-d","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0861579265.USD","PAWZ","LU1116320901.HKD","LU2125909247.SGD","MRK","PPH","LU2125909593.SGD","LU0965509101.SGD","BK4588","SG9999001440.SGD","IHE","LU2491049909.HKD","BK4533","IE00BBT3K403.USD","LU1941712348.USD","LU0234572021.USD","BK4559","LU2112291526.USD","IE00BLSP4452.SGD","LU0965509010.AUD","LU0058720904.USD","BK4585","LU1585245621.USD","LU2361045086.USD","LU1989772840.SGD","RXL","LU0980610538.SGD","LU1699723380.USD","IE0009355771.USD","LU2468319806.SGD","LU0265550946.USD","LU0965509283.SGD","IXJ","LU1929549753.HKD","FTXH","LU0070302665.USD","SG9999002232.USD","LU0823416689.USD","LU0289739699.SGD","LU1989771016.USD","LU2360032135.SGD","LU0098860793.USD","LU1057294990.SGD","IE00BLSP4239.USD","LU1291159041.SGD","IE00BN8TJ469.HKD","BMED","LU1162221912.USD","IE00B1BXHZ80.USD","LU0985320562.USD","LU1430594728.SGD","IE00BSNM7G36.USD","LU0965508806.USD","LU1201861249.SGD","LU0106261372.USD","LU2089984988.USD","LU2491050154.USD","XLV","SG9999014559.SGD","GDOC","IE00BFTCPJ56.SGD","LU0130102774.USD","VHT","LU0689626769.HKD","LU1974910355.USD","LU0265550359.USD","BK4534","LU1983299246.USD","LU0124676726.USD","FHLC","SG9999014575.USD","LU1917777945.USD","SG9999015341.SGD","LU1037948897.HKD","LU0942090050.USD","LU0859254822.USD","LU1035773651.USD","BK4007","LU2361044949.HKD","HRTS","LU1066051498.USD","LU0208291251.USD","LU1923622614.USD","LU1023059063.AUD","LU0122379950.USD","LU0320765489.SGD","IE0002141913.USD","LU0648001328.SGD","LU0130517989.USD","SG9999001176.USD","LU0266013472.USD","LU1037948541.HKD","IE00B2B36J28.USD","SG9999001176.SGD","IE000M9KFDE8.USD","LU1116320737.USD","LU2125154935.USD","SG9999015358.SGD","JDOC","LU2106854487.HKD","LU2433249047.HKD","BK4516","SG9999013999.USD","LU0006306889.USD","LU2023250504.SGD","LU2357627491.SGD","LU1061106388.HKD","LU1571399168.USD","LU1093756168.USD","LU2361044865.SGD","IYH","LU1066051811.HKD","LU1934455277.USD","LU0320765646.SGD","LU0868494708.USD","LU2023250843.SGD","LU0203347892.USD","LU1941712264.USD","SG9999002224.SGD","IE00B4R5TH58.HKD","LU1934455863.HKD","LU0868494617.USD","LU1989772923.USD","LU1069347547.HKD","LU1066053197.SGD","LU1934455194.USD","LU0432979614.USD","LU2125154778.USD","LU0238689110.USD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","BK4550","LU0211331839.USD","LU1066051225.USD","SG9999014542.SGD","TRUH","LU2491050071.SGD","SG9999014567.USD","LU0477156953.USD","SGXZ57979304.SGD","LU2461242641.AUD","LU1093756325.SGD","LU0203345920.USD","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662320194","title":"US FDA Expands Approval for J&J's Drug for Rare Blood Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2662320194","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662320194?lang=en_us&edition=fundamental","pubTime":"2026-08-25 06:32","pubTimestamp":1787610721,"startTime":"0","endTime":"0","summary":"US FDA expands approval for J&J's drug for rare blood disorderAug 24 (Reuters)-The U.S. Food and Drug Administration has approved the expanded use of Johnson & Johnson'sJNJ.Ndrug to treat a rare blood disorder, the company said on Monday.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL4N44L1IK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1145028129.USD","IE00BLSP4239.USD","LU0985320562.USD","LU1551013342.USD","IE00BJT1NW94.SGD","IE00BZ1G4Q59.USD","LU0098860793.USD","LU1935042991.SGD","IE00BDGV0183.EUR","FHLC","PJP","RXL","IE00BSNM7G36.USD","IHE","LU2089984988.USD","IE00BKVL7J92.USD","XLV","LU2129689514.USD","BK4504","LU1732799900.SGD","LU1989771016.USD","LU1585245621.USD","LU1894683264.USD","IXJ","LU2236285917.USD","BK4550","IE0002270589.USD","SGXZ80539844.SGD","LU2756315664.SGD","SG9999001176.SGD","GDOC","LU1196500208.SGD","LU2468319806.SGD","LU1244550577.SGD","JNJ","BMED","LU2430703095.HKD","MEDX","IYH","LU0787776722.HKD","IE00B3T34201.USD","TRUH","LU0345770993.USD","IE00BN8TJ469.HKD","LU0124676726.USD","VHT","IE00B7SZLL34.SGD","FTXH","JDOC","LU2456880835.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662913201","title":"FDA Approves J&J Imaavy for Warm Autoimmune Hemolytic Anemia Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2662913201","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662913201?lang=en_us&edition=fundamental","pubTime":"2026-08-25 06:31","pubTimestamp":1787610683,"startTime":"0","endTime":"0","summary":"FDA approves J&J IMAAVY for warm autoimmune hemolytic anemia treatmentFDA cleared IMAAVY  for warm autoimmune hemolytic anemia in patients aged 12+ who are current or prior corticosteroid users.Decision makes IMAAVY the first treatment specifically proven safe and effective for wAIHA, based on the Phase 2/3 ENERGY trial.Trial data showed a mean hemoglobin increase of 1 g/dL at Week 1, with improved FACIT-Fatigue scores at Week 24.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Johnson & Johnson published the original content used to generate this news brief on August 24, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL9KyWks:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1732799900.SGD","LU2129689605.HKD","FTXH","LU2602419157.SGD","IHE","IYH","LU1221951129.SGD","JDOC","RXL","LU1059921491.USD","MEDX","SGXZ80539844.SGD","LU0689626769.HKD","BMED","LU0792757196.USD","BK4504","LU2129689514.USD","LU2505996509.AUD","LU2430703251.USD","LU0545562505.USD","LU2471134796.USD","IE0034235303.USD","LU0820561909.HKD","LU1244550494.USD","LU1585245621.USD","LU0124676726.USD","LU0795875086.SGD","LU2347655156.SGD","SG9999001440.SGD","IE0002270589.USD","GDOC","PJP","IE000SO60NU8.SGD","LU1032466523.USD","JNJ","LU1066051225.USD","XLV","IE00BFXG1179.USD","LU1674673428.USD","IE00B3PB1722.GBP","FHLC","TRUH","SGXZ57979304.SGD","IXJ","VHT","IE00BVYPNW00.USD","LU0640476718.USD","LU0234572021.USD","LU0683600562.USD","LU2133065610.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662016052","title":"FDA Approves Imaavy® as First-Ever Treatment for Warm Autoimmune Hemolytic Anemia (Waiha), Representing a Landmark Advancement for Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2662016052","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662016052?lang=en_us&edition=fundamental","pubTime":"2026-08-25 06:29","pubTimestamp":1787610556,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nFWN44L0LI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0640476718.USD","BMED","IE00B19Z3B42.SGD","LU0122379950.USD","LU1261432733.SGD","LU2487616109.SGD","IE000BZT7R73.USD","IE00B42XCP33.USD","LU2430703178.SGD","MEDX","LU1228905540.USD","SG9999002224.SGD","LU1162221912.USD","LU1043141396.HKD","IHE","SG9999002232.USD","LU0070217475.USD","LU2347655156.SGD","IXJ","JNJ","LU0114720955.EUR","BK4532","IE00BDGV0183.EUR","LU0345769128.USD","FHLC","LU1244550221.USD","LU0466842654.USD","LU1061106388.HKD","IYH","GDOC","FTXH","SGXZ57979304.SGD","LU1506573853.SGD","VHT","JDOC","LU0345769631.USD","LU1280957306.USD","TRUH","XLV","IE0034235303.USD","PJP","LU2756315664.SGD","IE0002270589.USD","LU0964807845.USD","LU0889566641.SGD","RXL","LU1221951046.USD","LU0426417589.USD","LU0124676726.USD","LU2129689514.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662820617","title":"Moderna Inc. Stock Slides 4.3%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2662820617","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662820617?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:34","pubTimestamp":1787603640,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. slipped 4.3% to $138.89 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.3% to 53,417.16 and the NASDAQ Composite Index falling 0.8% to 25,980.19.Moderna Inc. closed 21.4% short of its 52-week high of $176.66, which the company reached on August 19th.The stock underperformed when compared to some of its peers, as Johnson & Johnson rose 1.0% to $273.04, Pfizer Inc. fell 0.4% to $27.97, and Gilead Sciences Inc. rose 0.42% to $146.74.Trading volume totaled 31.3 million, compared to the 50-day average of 14.7 million.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","BMED","LU1037948897.HKD","BK4139","IE00B3T34201.USD","IE00B19Z3B42.SGD","LU0859254822.USD","LU0122379950.USD","LU1061106388.HKD","IDNA","LU2357627491.SGD","GILD","LU0114720955.EUR","BIB","LU0965509283.SGD","LU1839511570.USD","LU2324357040.USD","LU2468319806.SGD","IBB","LU2089984988.USD","SG9999015986.USD","IBBQ","LU0320765992.SGD","LU0109394709.USD","LU1057294990.SGD","BK4534","MRNA","TBXU","MRNY","BK4532","GNOM","WDNA","LU0289739699.SGD","BBH","BK4568","LU0234570918.USD","MRNX","SG9999015952.SGD","LU1037948541.HKD","LU1934455277.USD","IE00B19Z3581.USD","LU1585245621.USD","BK4566","IE0002270589.USD","LGHT","MEDI","BK4548","BK4578","IE00BKVL7J92.USD","TMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662205709","title":"Lakefront Biotherapeutics Wins FDA Orphan Drug Status for Gamgertamig in Pemphigus","url":"https://stock-news.laohu8.com/highlight/detail?id=2662205709","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662205709?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:01","pubTimestamp":1787601693,"startTime":"0","endTime":"0","summary":"Lakefront Biotherapeutics wins FDA orphan drug status for gamgertamig in pemphigusFDA granted orphan drug designation to gamgertamig for pemphigus.The drug already holds FDA fast track and orphan stat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL5cnKbj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","BCDF","IE00BQXX3C00.GBP","IE00BN0W2V16.EUR","LU1023059063.AUD","BIB","LU2095319765.USD","IE00B64PRP62.GBP","BK4578","NDAQ","TMED","LU2089984988.USD","IE00BQXX3F31.USD","LU1674673691.USD","LU0859254822.USD","IE00BZ1G4Q59.USD","LU1037948541.HKD","LU1430594728.SGD","LU0122379950.USD","GILD","LU2324357040.USD","LU0965508806.USD","BK4139","LU2087621335.USD","LU2210150020.SGD","BMED","LU0861579265.USD","IE00BKPKM429.USD","IE00BN0W2T93.GBP","BK4566","LU1066051498.USD","SG9999015978.USD","BBH","TBXU","MEDI","IBB","LU0234570918.USD","LU0320765992.SGD","BK4550","IE0002270589.USD","IE00BN0W2W23.USD","LU2210149790.SGD","LU0965509010.AUD","LU0289739699.SGD","SG9999015952.SGD","BK4568","IBBQ","IE00BKVL7J92.USD","IE00B19Z3B42.SGD","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662204407","title":"Syngenis banks R&D refund to fuel biotech build-out","url":"https://stock-news.laohu8.com/highlight/detail?id=2662204407","media":"The West Australian","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662204407?lang=en_us&edition=fundamental","pubTime":"2026-08-24 23:06","pubTimestamp":1787584007,"startTime":"0","endTime":"0","summary":"Biotech hopeful Syngenis Labs has banked a $363,000 R&D tax refund atop a recent $4 million pre-IPO raise, adding non-dilutive firepower as it builds out its Australian RNA and DNA manufacturing platform.","market":"us","thumbnail":"https://images.thewest.com.au/publication/C-22771960/cfe32dd8d5c27df108386c3ef5f67af0dd0eab91.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-22771960/cfe32dd8d5c27df108386c3ef5f67af0dd0eab91.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/business/bulls-n-bears/syngenis-banks-rd-refund-to-fuel-biotech-build-out-c-22771960","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/business/bulls-n-bears/syngenis-banks-rd-refund-to-fuel-biotech-build-out-c-22771960","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["BMED","BK4144","NVIB","XBIX","GLP","BK4590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661285272","title":"Moderna is Betting Big on Its Cancer Vaccine. This is What Wall Street Wants to See.","url":"https://stock-news.laohu8.com/highlight/detail?id=2661285272","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661285272?lang=en_us&edition=fundamental","pubTime":"2026-08-24 22:45","pubTimestamp":1787582700,"startTime":"0","endTime":"0","summary":"Top executives at Moderna have been projecting high confidence in the commercial future of the company's personalized cancer vaccine even as Wall Street holds out for complete trial results.The market","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","IE00BN8TJ469.HKD","BK4139","BK4501","LU1116320737.USD","LU1941712264.USD","IDNA","LU0320765489.SGD","FTXH","LU2361044865.SGD","LU1989772923.USD","LU2324357040.USD","VHT","LU0234572021.USD","MRNA","MRNY","BK4532","GNOM","WDNA","RXL","LU0868494708.USD","BK4568","MRNX","IXJ","MRK","LU0058720904.USD","XLV","IHE","JDOC","LU1037948541.HKD","LU1917777945.USD","LU2361045086.USD","LU2491050154.USD","LU0211331839.USD","IYH","RCC","GDOC","HRTS","LU0124676726.USD","LU0203347892.USD","PAWZ","LGHT","PPH","LU0208291251.USD","TRUH","LU0238689110.USD","IE00BJT1NW94.SGD","BK4585","FHLC","SG9999015358.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661271017","title":"Renalytix Discloses Director’s Link to Trellus Administration as KidneyIntelX Rollout Advances","url":"https://stock-news.laohu8.com/highlight/detail?id=2661271017","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661271017?lang=en_us&edition=fundamental","pubTime":"2026-08-24 21:42","pubTimestamp":1787578963,"startTime":"0","endTime":"0","summary":"Renalytix ( ($GB:RENX) ) has issued an update. Renalytix plc, a London- and New York-based precision medicine diagnostics group, specializes in art...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/renalytix-discloses-directors-link-to-trellus-administration-as-kidneyintelx-rollout-advances?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/renalytix-discloses-directors-link-to-trellus-administration-as-kidneyintelx-rollout-advances?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNMX","WDNA","LFSC","TMAT","HTEC","FDIF","BK4585","IDNA","GNOM","XT","HELX","BMED","PBE","SYNB","BK4588","IBB","MEDX","JDOC","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661127910","title":"Biogen, Eisai's LEQEMBI IQLIK Now Available in US for Early Alzheimer's Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2661127910","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661127910?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:55","pubTimestamp":1787576112,"startTime":"0","endTime":"0","summary":"Biogen  and Japanese pharmaceutical company Eisai said Monday that LEQEMBI IQLIK, a once-weekly autoinjector formulation of lecanemab-irmb, is now available in the US for initiation therapy in adults with early Alzheimer's disease.The treatment is indicated for patients with mild cognitive impairment or mild dementia due to Alzheimer's disease.The drug is administered using an autoinjector to provide 500 mg once a week in two consecutive 250 mg injections, with each injection taking about 15 seconds to deliver.LEQEMBI IQLIK is available through the LEQEMBI Specialty Pharmacy Network, the companies said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0109394709.USD","BK4585","LU0320765992.SGD","BK4588","PBE","IE00B19Z9P08.USD","BIIB","BK4139","IE00B894F039.SGD","LU0234570918.USD","BK4533","LU0889565916.HKD","BMED","IE00B19Z9Z06.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661279670","title":"Eisai, Biogen announces once weekly lecanemab-irmb availability in the U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2661279670","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661279670?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:40","pubTimestamp":1787575209,"startTime":"0","endTime":"0","summary":"Eisai (ESAIY) and Biogen (BIIB) announced that once weekly lecanemab-irmb subcutaneous injection is now available in the U.S. for initiation therap...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eisai-biogen-announces-once-weekly-lecanemab-irmb-availability-in-the-u-s-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eisai-biogen-announces-once-weekly-lecanemab-irmb-availability-in-the-u-s-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","BK4585","BK4588","IE00B19Z9P08.USD","IE00B894F039.SGD","ESAIY","PBE","IE00B19Z9Z06.USD","LU0234570918.USD","BK4007","BK4533","BMED","BK4532","LU0109394709.USD","BIIB","BK4139","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661313276","title":"Eisai Co., Ltd.: Leqembi Iqlik (Lecanemab-Irmb) Autoinjector for Initiation of Therapy NOW Available in U.S. for Early Alzheimer's Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2661313276","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661313276?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:02","pubTimestamp":1787572944,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nFWN44L0JX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0320765992.SGD","IE00B19Z9P08.USD","BK4585","BK4139","BK4532","IE00B19Z9Z06.USD","BK4588","IE00B894F039.SGD","BK4533","PBE","LU0234570918.USD","LU0889565916.HKD","LU0109394709.USD","BIIB","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144024774","title":"CF PHARMTECH (02652) Secures Expanded Clinical Trial Approval for ICF001 Across Additional Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=1144024774","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144024774?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:41","pubTimestamp":1787571660,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) has announced that its independently developed long-acting inhaled dry powder candidate drug, ICF001, has received implied clinical trial approval from the National Medical...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","PSYK","IBBJ","MDTX","02652","BK1191","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661273955","title":"Barclays Raises Moderna PT on 'transformative' Melanoma Vaccine Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2661273955","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661273955?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:04","pubTimestamp":1787569487,"startTime":"0","endTime":"0","summary":"BUZZ-Barclays raises Moderna PT on 'transformative' melanoma vaccine potential** Barclays raises PT on vaccine maker ModernaMRNA.Oto $125 from $48, maintains \"equal weight\" rating** New PT implies a 1","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL6N44L0K6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0868494708.USD","LU1116320901.HKD","MRNA","IE00B4R5TH58.HKD","LU1066051811.HKD","LU1201861249.SGD","BK4534","LU1291159041.SGD","LU1989771016.USD","XLV","LU2106854487.HKD","IDNA","LU2023250504.SGD","MRNY","LU2023250843.SGD","IE0002141913.USD","LU1066051498.USD","SGXZ57979304.SGD","LU0965509101.SGD","SG9999014542.SGD","LU1929549753.HKD","LU0122379950.USD","LU1934455277.USD","BK4585","IE00BJJMRZ35.SGD","LU0985320562.USD","LU0265550359.USD","FTXH","LU2491050071.SGD","LU2089984988.USD","LU1941712348.USD","LU1923622614.USD","SG9999014575.USD","LU2361045086.USD","LU2360032135.SGD","BK4548","SG9999001176.SGD","LU0238689110.USD","LU0266013472.USD","WDNA","BK4533","SG9999014559.SGD","LU0006306889.USD","PPH","SG9999015341.SGD","LU0965509283.SGD","LU1989772923.USD","LU1934455863.HKD","LU0868494617.USD","LU2491049909.HKD","VHT","IYH","BK4588","GDOC","LU2112291526.USD","BK4559","LU1037948897.HKD","LU0689626769.HKD","LU0106261372.USD","HRTS","IE00BSNM7G36.USD","LU1983299246.USD","BK4139","LU0823416689.USD","LU1066051225.USD","LU2125154778.USD","IE00B2B36J28.USD","LU0265550946.USD","LU1430594728.SGD","IE000M9KFDE8.USD","LU0648001328.SGD","LU1699723380.USD","LU1917777945.USD","LU2357627491.SGD","LU0208291251.USD","LU0432979614.USD","BK4501","LU1037948541.HKD","SG9999015358.SGD","GNOM","LU1066053197.SGD","LU2125909593.SGD","FHLC","MRNX","LU0130517989.USD","LU0861579265.USD","LU1069347547.HKD","LU2461242641.AUD","LU0203345920.USD","LU1989772840.SGD","SG9999014567.USD","LU1023059063.AUD","LU1934455194.USD","SG9999001440.SGD","IHE","LU1585245621.USD","LU1974910355.USD","SG9999002232.USD","LU0477156953.USD","BK4516","IE00B1BXHZ80.USD","LU1057294990.SGD","BK4550","IE00BLSP4239.USD","LU0203347892.USD","PAWZ","BK4007","SG9999001176.USD","BK4568","LU0320765489.SGD","LU1093756325.SGD","LU2361044865.SGD","BK4532","LU0070302665.USD","IE0009355771.USD","LU0980610538.SGD","JDOC","LU0211331839.USD","IXJ","LU0859254822.USD","LU0320765646.SGD","LU0965509010.AUD","LU1571399168.USD","LGHT","LU1941712264.USD","LU0289739699.SGD","LU2125909247.SGD","LU1093756168.USD","IE00BJT1NW94.SGD","LU2324357040.USD","LU2468319806.SGD","LU0098860793.USD","LU0130102774.USD","BMED","LU2491050154.USD","BK4551","LU1116320737.USD","SG9999002224.SGD","IE00BLSP4452.SGD","LU1035773651.USD","LU0965508806.USD","LU2125154935.USD","LU2361044949.HKD","LU0058720904.USD","LU0234572021.USD","IE00BFTCPJ56.SGD","LU1162221912.USD","RXL","IE00BBT3K403.USD","LU0124676726.USD","MRK","LU2433249047.HKD","LU1061106388.HKD","IE00BN8TJ469.HKD","SG9999013999.USD","LU0942090050.USD","TRUH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661278374","title":"EU Commission Approves Gilead Trodelvy-Keytruda Combo for First-Line PD-L1+ Metastatic TNBC","url":"https://stock-news.laohu8.com/highlight/detail?id=2661278374","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661278374?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:31","pubTimestamp":1787567503,"startTime":"0","endTime":"0","summary":"EU Commission approves Gilead Trodelvy-Keytruda combo for first-line PD-L1+ metastatic TNBCEuropean Commission granted marketing authorization for Trodelvy with Merck’s Keytruda in first-line metastat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL4gZS8y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0859254822.USD","IE00B3T34201.USD","BK4550","SG9999015978.USD","LU1934455863.HKD","IE00B19Z3581.USD","LU1674673691.USD","IBB","LU0289739699.SGD","LU0109394709.USD","LU0114720955.EUR","BK4566","LU2089984988.USD","SG9999015952.SGD","IE0002270589.USD","TBXU","LU1934455277.USD","LU0058720904.USD","LU0965508806.USD","LU0965509283.SGD","BIB","IBBQ","LU1934455194.USD","MEDI","LU2357627491.SGD","BK4583","BMED","BBH","LU1778281490.HKD","LU0965509101.SGD","LU1066051498.USD","LU1057294990.SGD","LU0320765992.SGD","LU1571399168.USD","LU2468319806.SGD","LU0823416689.USD","BK4585","LU1023059063.AUD","LU1585245621.USD","LU1037948897.HKD","SG9999015986.USD","LU1061106388.HKD","LU0861579265.USD","LU1037948541.HKD","TMED","LU0965509010.AUD","GILD","LU1430594728.SGD","IE00BZ1G4Q59.USD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661325278","title":"Gilead - EU Grants Marketing Authorization for Trodelvy with Keytruda in First-Line Pd-L1-Positive Metastatic Tnbc","url":"https://stock-news.laohu8.com/highlight/detail?id=2661325278","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661325278?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:31","pubTimestamp":1787567460,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUAMP4X3:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2324357040.USD","SG9999015978.USD","LU1934455194.USD","LU1023059063.AUD","IBB","IE00BSNM7G36.USD","IE00BZ1G4Q59.USD","LU1066053197.SGD","LU1674673428.USD","LU0965509010.AUD","LU1934455863.HKD","LU0289739699.SGD","IE00B3T34201.USD","LU0234570918.USD","BIB","SG9999015945.SGD","BMED","LU0320765992.SGD","IE00B7SZLL34.SGD","LU1037948897.HKD","TMED","LU1839511570.USD","IBBQ","BBH","SG9999015986.USD","LU1585245621.USD","TBXU","BK4139","BK4585","LU2468319806.SGD","BK4566","BK4568","LU0889565916.HKD","LU0965509101.SGD","LU1061106388.HKD","LU1057294990.SGD","LU0965509283.SGD","BK4588","GILD","LU2357627491.SGD","LU0058720904.USD","BK4550","LU1066051498.USD","LU0965508806.USD","MEDI","IE00B19Z3B42.SGD","LU1674673691.USD","SG9999015952.SGD","LU1934455277.USD","IE0002270589.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661278323","title":"European Commission Expands Role of Gilead’s Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer Across Pd-L1 Status","url":"https://stock-news.laohu8.com/highlight/detail?id=2661278323","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661278323?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:31","pubTimestamp":1787567460,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUAMP4X3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","LU1037948541.HKD","BK4583","LU0889565916.HKD","IE00BKVL7J92.USD","LU1585245621.USD","IE00B7SZLL34.SGD","LU0109394709.USD","BIB","LU0861579265.USD","IBB","TMED","BK4139","LU0882574055.USD","IE00B19Z3B42.SGD","LU1674673691.USD","LU0823416689.USD","LU1061106388.HKD","BK4566","SG9999015986.USD","LU1674673428.USD","LU2324357040.USD","BMED","LU0320765992.SGD","IBBQ","BK4585","IE00B19Z3581.USD","BK4588","LU1066053197.SGD","LU0965509101.SGD","SG9999015952.SGD","LU0289739699.SGD","LU0114720955.EUR","LU1934455863.HKD","BK4568","SG9999015945.SGD","LU1037948897.HKD","LU0859254822.USD","LU1057294990.SGD","LU2087621335.USD","LU0122379950.USD","LU0058720904.USD","BBH","MEDI","GILD","LU0234570918.USD","SG9999015978.USD","LU2357627491.SGD","TBXU","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181313648","title":"BAO PHARMA-B (02659) Receives US FDA Clearance for KJ015 Injection Clinical Trial Application","url":"https://stock-news.laohu8.com/highlight/detail?id=1181313648","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181313648?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:08","pubTimestamp":1787566138,"startTime":"0","endTime":"0","summary":"BAO PHARMA-B (02659) has announced that on August 21, 2026, its independently developed KJ015 injection, a subcutaneous formulation of a bispecific antibody targeting HER2, received Investigational...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBJ","LABU","BK4588","PSYK","BK1161","MDTX","BMED","IBBQ","02659","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":13,"pageCount":1,"totalSize":245,"code":"91000000","status":"200"}]}}